Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1953 3
1955 2
1956 3
1958 1
1960 2
1961 1
1962 2
1963 1
1966 2
1967 1
1968 3
1969 1
1970 1
1971 4
1972 4
1973 9
1974 9
1975 4
1976 11
1977 11
1978 11
1979 11
1980 10
1981 11
1982 9
1983 11
1984 12
1985 10
1986 14
1987 23
1988 25
1989 24
1990 13
1991 43
1992 40
1993 38
1994 41
1995 47
1996 43
1997 60
1998 66
1999 71
2000 85
2001 73
2002 94
2003 152
2004 145
2005 185
2006 219
2007 266
2008 238
2009 296
2010 337
2011 332
2012 378
2013 392
2014 419
2015 489
2016 553
2017 569
2018 623
2019 656
2020 697
2021 858
2022 919
2023 837
2024 911
2025 884
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,009 results

Results by year

Filters applied: . Clear all
Page 1
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Hofman MS, Emmett L, Sandhu S, Iravani A, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, McJannett MM, Stockler MR, Violet JA, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Among authors: lin p. Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11. Lancet. 2021. PMID: 33581798 Clinical Trial.
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Cancer Genome Atlas Research Network; Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fenn… See abstract for full author list ➔ Cancer Genome Atlas Research Network, et al. Among authors: lin p. N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10. N Engl J Med. 2015. PMID: 26061751 Free PMC article.
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.
Biederstädt A, Basar R, Park JM, Uprety N, Shrestha R, Reyes Silva F, Dede M, Watts J, Acharya S, Xiong D, Liu B, Daher M, Rafei H, Banerjee P, Li P, Islam S, Fan H, Shanley M, Jin J, Kumar B, Woods V, Lin P, Tiberti S, Nunez Cortes AK, Jiang XR, Biederstädt I, Zhang P, Li Y, Rawal S, Liu E, Muniz-Feliciano L, Deyter GM, Shpall EJ, Fowlkes NW, Chen K, Rezvani K. Biederstädt A, et al. Among authors: lin p. Cancer Cell. 2025 Nov 10;43(11):2069-2088.e11. doi: 10.1016/j.ccell.2025.07.021. Epub 2025 Aug 21. Cancer Cell. 2025. PMID: 40845844 Free PMC article.
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial.
Emmett L, Subramaniam S, Crumbaker M, Joshua AM, Sandhu S, Nguyen A, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Gedye C, Rutherford NK, Kumar ASR, Pook D, Ramdave S, Nadebaum DP, Voskoboynik M, Redfern AD, Macdonald W, Krieger L, Schembri G, Chua W, Lin P, Horvath L, Bastick P, Butler P, Zhang AY, McJannett M, Thomas H, Langford A, Hofman MS, Martin AJ, Davis ID, Stockler MR; ENZA-p Trial Investigators; Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Emmett L, et al. Among authors: lin p. Lancet Oncol. 2025 Mar;26(3):291-299. doi: 10.1016/S1470-2045(25)00009-9. Epub 2025 Feb 13. Lancet Oncol. 2025. PMID: 39956124 Clinical Trial.
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.
Rafei H, Basar R, Acharya S, Hsu YS, Liu P, Zhang D, Bohn T, Liang Q, Mohanty V, Upadhyay R, Li P, Phadatare P, Dede M, Xiong D, Fan H, Jones CM, Kunz S, Daher M, Nunez Cortes AK, Shanley M, Liu B, Moseley SM, Zhang C, Fang D, Banerjee P, Uprety N, Li Y, Shrestha R, Wan X, Shen H, Woods V, Gilbert AL, Rawal S, Dou J, Tan Y, Park JM, Reyes Silva F, Biederstädt A, Kaplan M, Jiang XR, Biederstädt I, Kumar B, Tiberti S, Moore M, Jin J, Yang RZ, Muniz-Feliciano L, Rosemore S, Lin P, Deyter GM, Fowlkes NW, Jain AK, Marin D, Maitra A, Chen K, Bopp T, Shpall EJ, Rezvani K. Rafei H, et al. Among authors: lin p. Nature. 2025 Jul;643(8073):1076-1086. doi: 10.1038/s41586-025-09087-8. Epub 2025 Jun 4. Nature. 2025. PMID: 40468083 Free PMC article.
A highly stable monomeric red fluorescent protein for advanced microscopy.
Xiong H, Chang Q, Ding J, Wang S, Zhang W, Li Y, Wu Y, Lin P, Yang C, Liu M, Fang G, Yang Y, Xie J, Qi D, Jiang T, Fu W, Hu F, Chen Y, Yue R, Li Y, Cui Y, Li M, Fan S, Yang Y, Xu Y, Li D, Zhang F, Zhao H, Wu C, Zheng Q, Piatkevich KD, Fu Z. Xiong H, et al. Among authors: lin p. Nat Methods. 2025 Jun;22(6):1288-1298. doi: 10.1038/s41592-025-02676-5. Epub 2025 Apr 17. Nat Methods. 2025. PMID: 40247125
Molecular crystal memristors.
Qin L, Guan P, Shao J, Xiao Y, Yu Y, Su J, Zhang C, Li Y, Liu S, Li P, Ouyang D, He W, Liu F, Zhu K, Liu K, Yao Z, Wu J, Zhao Y, Li H, Hui F, Lin P, Lanza M, Li Y, Zhai T. Qin L, et al. Among authors: lin p. Nat Nanotechnol. 2025 Nov;20(11):1641-1647. doi: 10.1038/s41565-025-02013-z. Epub 2025 Sep 17. Nat Nanotechnol. 2025. PMID: 40962872
Integrated multiomics of pressure overload in the human heart prioritizes targets relevant to heart failure.
Lindman BR, Perry AS, Lance ML, Amancherla K, Kim N, Sheng Q, Lin P, Pfeiffer RD, Farber-Eger E, Fearon WF, Kapadia S, Kumbhani DJ, Gillam L, Mallugari RR, Gupta DK, Miller FJ, Vatterott A, Jackson N, Su YR, Tomasek K, Absi T, Freedman JE, Nayor M, Das S, Wells QS, Dweck MR, Gerszten RE, Gamazon ER, Tucker NR, Shah R, Elmariah S. Lindman BR, et al. Among authors: lin p. Nat Commun. 2025 Jul 26;16(1):6889. doi: 10.1038/s41467-025-62201-2. Nat Commun. 2025. PMID: 40715126 Free PMC article.
11,009 results
You have reached the last available page of results. Please see the User Guide for more information.